GRI BIO, INC.— Sankey Diagram
Quarterly mode · period ending 2023-03-31 · SEC EDGAR
ComparingFY2023 (Q4) vs FY2022 (Q4)
Revenue
$16K
Gross Profit
$16K
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2023 (Q4) | FY2022 (Q4) |
|---|---|---|
| Revenue | $16K | $0 |
| COGS | $0 | $0 |
| Gross Profit | $16K | $0 |
| R&D | $116K | $1M |
| SG&A | $0 | $0 |
| D&A | $1K | $0 |
| Other OpEx | $0 | $0 |
| Operating Income | $0 | $0 |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · GRI · Comparing FY2023 (Q4) vs FY2022 (Q4)